Integral Diagnostics Limited re-affirmed earnings guidance for the fiscal year 2017. The company confirmed that it's underlying NPAT full year result is expected to be within the fiscal year 2017 guidance previously provided with the company's half year result in February 2017, before accounting for a write-off of $0.776 million after tax.